Download Current Opinion in Immunology 2009, 21:440–445 Biomarkers of

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Germ theory of disease wikipedia , lookup

Childhood immunizations in the United States wikipedia , lookup

Immunocontraception wikipedia , lookup

Polyclonal B cell response wikipedia , lookup

Adaptive immune system wikipedia , lookup

Cancer immunotherapy wikipedia , lookup

Autoimmunity wikipedia , lookup

Schistosomiasis wikipedia , lookup

Common cold wikipedia , lookup

Vaccination wikipedia , lookup

Hospital-acquired infection wikipedia , lookup

Immune system wikipedia , lookup

Sarcocystis wikipedia , lookup

Hepatitis B wikipedia , lookup

Neonatal infection wikipedia , lookup

Immunosuppressive drug wikipedia , lookup

Infection wikipedia , lookup

Innate immune system wikipedia , lookup

Chickenpox wikipedia , lookup

Herd immunity wikipedia , lookup

Infection control wikipedia , lookup

Immunomics wikipedia , lookup

Sociality and disease transmission wikipedia , lookup

Social immunity wikipedia , lookup

Hygiene hypothesis wikipedia , lookup

Psychoneuroimmunology wikipedia , lookup

Transcript
Current Opinion in Immunology 2009, 21:440–445
Biomarkers of human immunosenescence: impact of
Cytomegalovirus infection
Evelyna Derhovanessian, Anis Larbi and Graham Pawelec
Lay summary
Age-associated failing immunity, or “immunosenescence”, contributes to the increased
incidence and severity of infectious disease in old people. Which of the multitude of ageassociated alterations thus far reported are causally-related to a person´s health and longevity
is not known. If we could identify the mechanisms of immune ageing and intervene to restore
appropriate immunity, a long healthy lifespan might result. This is, however, an enormous
current challenge in a very long-lived species like humans. Circumstantial evidence and
longitudinal studies limited to the very elderly have begun to reveal “immune signatures” or
biomarkers of immune ageing consisting of several parameters which we have designated the
“immune risk profile”, or IRP. Although hinted at many years ago, a marked impact of
usually asymptomatic infection with the persistent β-herpesvirus Cytomegalovirus (CMV) on
markers of immunosenescence is now becoming incontrovertible. The fascinating
cohabitation of CMV with the human immune system, which commits a very significant
fraction of its entire resources to CMV-immunosurveillance, may suggest an early-life benefit
from infection, which becomes deleterious for the majority of the population only in later life
or under pathological conditions.